Literature DB >> 20217202

Hyponatremic and hepatic encephalopathies: similarities, differences and coexistence.

Juan Córdoba1, Rita García-Martinez, Macarena Simón-Talero.   

Abstract

Hyponatremic and hepatic encephalopathy are common causes of metabolic encephalopathy that may coexist in patients with cirrhosis. The clinical picture is common to any metabolic encephalopathy and is characterized by a confusional syndrome that may evolve into coma. Chronic mild or minimal manifestations can be seen in both, but motor symptoms are more common in hepatic encephalopathy. Recent advances show that in addition to clinical manifestations both encephalopathies share some pathogenetic mechanisms. Dysfunction of astrocytes, osmotic changes in the brain and brain edema are present in both situations. Recognition of these abnormalities is important to plan therapy. New drugs that affect brain hydration may be useful for both encephalopathies.

Entities:  

Mesh:

Year:  2010        PMID: 20217202     DOI: 10.1007/s11011-010-9172-3

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  55 in total

1.  Effects on the central nervous system of hypernatremic and hyponatremic states.

Authors:  A I Arieff; R Guisado
Journal:  Kidney Int       Date:  1976-07       Impact factor: 10.612

Review 2.  Delirium in older persons.

Authors:  Sharon K Inouye
Journal:  N Engl J Med       Date:  2006-03-16       Impact factor: 91.245

3.  Elevation of intracranial pressure following transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage.

Authors:  R Jalan; K Dabos; D N Redhead; A Lee; P C Hayes
Journal:  J Hepatol       Date:  1997-11       Impact factor: 25.083

4.  Cerebral oedema and increased intracranial pressure in chronic liver disease.

Authors:  J P Donovan; D F Schafer; B W Shaw; M F Sorrell
Journal:  Lancet       Date:  1998-03-07       Impact factor: 79.321

5.  Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

Authors:  Peter Ferenci; Alan Lockwood; Kevin Mullen; Ralph Tarter; Karin Weissenborn; Andres T Blei
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

6.  T2 hyperintensity along the cortico-spinal tract in cirrhosis relates to functional abnormalities.

Authors:  Juan Córdoba; Nuria Raguer; Montserrat Flavià; Víctor Vargas; Carlos Jacas; Juli Alonso; Alex Rovira
Journal:  Hepatology       Date:  2003-10       Impact factor: 17.425

Review 7.  Aquaporin-4 in hepatic encephalopathy.

Authors:  K V Rama Rao; M D Norenberg
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

8.  Chronic hyponatremia exacerbates ammonia-induced brain edema in rats after portacaval anastomosis.

Authors:  J Córdoba; J Gottstein; A T Blei
Journal:  J Hepatol       Date:  1998-10       Impact factor: 25.083

9.  Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis.

Authors:  Mónica Guevara; M E Baccaro; Aldo Torre; Beatriz Gómez-Ansón; José Ríos; Ferrán Torres; Lorena Rami; Gemma C Monté-Rubio; Marta Martín-Llahí; Vicente Arroyo; Pere Ginès
Journal:  Am J Gastroenterol       Date:  2009-06       Impact factor: 10.864

10.  Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo.

Authors:  Barjesh Chander Sharma; Praveen Sharma; Amit Agrawal; Shiv Kumar Sarin
Journal:  Gastroenterology       Date:  2009-06-06       Impact factor: 22.682

View more
  22 in total

Review 1.  Acute-on-Chronic Liver Failure.

Authors:  Sumeet K Asrani; Douglas A Simonetto; Patrick S Kamath
Journal:  Clin Gastroenterol Hepatol       Date:  2015-07-15       Impact factor: 11.382

Review 2.  Electrolyte and Acid-Base Disturbances in End-Stage Liver Disease: A Physiopathological Approach.

Authors:  José Víctor Jiménez; Diego Luis Carrillo-Pérez; Rodrigo Rosado-Canto; Ignacio García-Juárez; Aldo Torre; David Kershenobich; Eduardo Carrillo-Maravilla
Journal:  Dig Dis Sci       Date:  2017-05-13       Impact factor: 3.199

Review 3.  Challenges in diagnosing hepatic encephalopathy.

Authors:  K Weissenborn
Journal:  Neurochem Res       Date:  2014-08-21       Impact factor: 3.996

4.  Correction of hyponatraemia improves cognition, quality of life, and brain oedema in cirrhosis.

Authors:  Vishwadeep Ahluwalia; Douglas M Heuman; George Feldman; James B Wade; Leroy R Thacker; Edith Gavis; HoChong Gilles; Ariel Unser; Melanie B White; Jasmohan S Bajaj
Journal:  J Hepatol       Date:  2014-08-08       Impact factor: 25.083

Review 5.  Water, electrolyte, acid-base, and trace elements alterations in cirrhotic patients.

Authors:  Carlos G Musso; Rossina Juarez; Richard J Glassock
Journal:  Int Urol Nephrol       Date:  2017-06-12       Impact factor: 2.370

Review 6.  Hepatic encephalopathy in acute-on-chronic liver failure.

Authors:  Guan-Huei Lee
Journal:  Hepatol Int       Date:  2015-05-28       Impact factor: 6.047

Review 7.  Acute-on-chronic liver failure: Pathogenesis, prognostic factors and management.

Authors:  Sara Blasco-Algora; José Masegosa-Ataz; María Luisa Gutiérrez-García; Sonia Alonso-López; Conrado M Fernández-Rodríguez
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

Review 8.  Encephalopathy and liver transplantation.

Authors:  Laia Chavarria; Juan Cordoba
Journal:  Metab Brain Dis       Date:  2012-11-16       Impact factor: 3.584

9.  Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis.

Authors:  Vishwadeep Ahluwalia; James B Wade; Leroy Thacker; Kenneth A Kraft; Richard K Sterling; R Todd Stravitz; Michael Fuchs; Iliana Bouneva; Puneet Puri; Velimir Luketic; Arun J Sanyal; Hochong Gilles; Douglas M Heuman; Jasmohan S Bajaj
Journal:  J Hepatol       Date:  2013-05-07       Impact factor: 25.083

Review 10.  Approach and management of dysnatremias in cirrhosis.

Authors:  Mauro Bernardi; Giacomo Zaccherini
Journal:  Hepatol Int       Date:  2018-09-10       Impact factor: 6.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.